Loading clinical trials...
Loading clinical trials...
BOTOX® (onabotulinumtoxinA) Treatment of Masseter Muscle Prominence: A Phase 2b, Multicenter, Randomized, Double-Blind, Multi-Dose, Placebo-Controlled Study
Conditions
Interventions
OnabotulinumtoxinA
Normal saline
Locations
14
United States
Total Skin & Beauty Dermatology Center, PC
Birmingham, Alabama, United States
Westside Aesthetics
Los Angeles, California, United States
Skin Care and Laser Physicians of Beverly Hills
Los Angeles, California, United States
Cosmetic Laser Dermatology
San Diego, California, United States
Baumann Cosmetic and Research Institute
Miami, Florida, United States
DeNova Research
Chicago, Illinois, United States
Start Date
May 16, 2019
Primary Completion Date
April 3, 2020
Completion Date
July 2, 2020
Last Updated
April 28, 2021
Lead Sponsor
Allergan
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions